about
Fourier transform infrared spectroscopy investigations of protein structure.Overview of membrane transport.Classification of membrane transporters.Drug transport and targeting. Intestinal transport.The molecular basis for hepatobiliary transport of organic cations and organic anions.Affinity of drugs to the different renal transporters for organic anions and organic cations.Drug disposition and targeting. Transport across the blood-brain barrier.The mammalian facilitative glucose transporter (GLUT) family.Cationic amino acid transporters (CATs). Targets for the manipulation of NO-synthase activity?Electrophysiological analysis of renal Na(+)-coupled divalent anion transporters.Dipeptide transporters.Antigenic peptide transporter.Nucleoside transporters of mammalian cells.Multidrug-resistance transporters.Transporters for bile acids and organic anions.Molecular and functional characteristics of cloned human organic cation transporters.Organic anion transporters.Vitamin B12 transporters.Practical approaches to protein formulation development.Rational design of stable lyophilized protein formulations: theory and practice.Spray-drying of proteins.Surfactant-protein interactions.High throughput formulation: strategies for rapid development of stable protein products.Recombinant production of native proteins from Escherichia coli.Physical stabilization of proteins in aqueous solution.Effects of conformation on the chemical stability of pharmaceutically relevant polypeptides.Dorzolamide, a 40-year wait. From an oral to a topical carbonic anhydrase inhibitor for the treatment of glaucoma.Preformulation studies as an essential guide to formulation development and manufacture of protein pharmaceuticals.Aseptic processing of protein pharmaceuticals.Fundamentals of thermal sterilization processes.Membrane filtration.Fundamentals of freeze-drying.Quality assurance and quality control for biopharmaceutical products.Regulatory considerations in the development of protein pharmaceuticals.Formulation development of protein dosage forms.Vaccine research and development for the prevention of filarial nematode infections.Mass spectrometry in protein structural analysis.Controlled delivery of somatotropins.Protein delivery from biodegradable microspheres.Nanoparticles as adjuvants for vaccines.
P1433
Q30423386-37A5A35C-039A-4A1D-8431-F1E7B1F7E225Q33878808-2B765573-386F-4E05-BF5C-4BA5160DC15FQ33878814-AE73AB02-6330-40E0-A48B-24B494A80F51Q33878819-3BD523C5-E8F6-451F-A2A2-E0BE80711B47Q33878824-B96D63DA-20FD-479D-89BF-D96BFC107391Q33878829-F1BDCBDB-8EAA-4D38-8B12-35AD616CA255Q33878834-A5526C45-5BF0-45AF-8DD8-A014C19EAE5AQ33878841-18E0C247-0FE7-42E1-9DA5-D17FC54900CFQ33878848-4DDDF789-9B90-4E06-B7FA-C090D3B46264Q33878856-D5D79A62-92E4-4EE5-A870-A9571A59C782Q33878860-90570106-1224-406E-A978-B73088E2BC46Q33878866-2EF80B81-D65C-46D1-9ADA-5A1E00A791F8Q33878873-737F8B2D-CB6D-4A4B-8B65-EB7A3B1C9719Q33878878-C9F5749D-B858-4BB3-A8AA-708BD36208CDQ33878884-975F2001-2844-4FBD-8AF2-1BB40160CC1DQ33878889-2D009241-899B-43ED-BFE9-CD3E92891F3DQ33878895-99F4089A-CB28-4863-A9FF-645D2A930B5CQ33878899-4FA73DC3-CC4F-4E8D-93A4-FA92D7EDDE99Q34622720-301613F6-833E-45C9-919A-FECFA6C0326DQ34622728-F38F4EB3-BF49-45B5-9C46-F75FBB94D38CQ34622735-1FA1FBA3-F8E6-4707-ADB3-CBB97C00EFCFQ34622740-9652ABB6-8440-4B95-9D1B-C6DD4F5EA462Q34622745-13274337-308B-4F0A-838C-F740F630F3B5Q34622753-762A8325-51D3-46D3-A810-18BC39FDD3C7Q34622759-03B22AD9-37A3-4369-90DF-94021E0D07B0Q34622767-94F8A7D8-A595-4F1D-A407-816B2425815BQ34753764-7AE1F237-F440-4B92-AF57-A75ADC3E6402Q34791499-50B3A80E-7B37-44D7-AB08-DA6954E2BD00Q34791508-27640AE5-8514-40AB-A59C-2B92DA3988CFQ34791516-3217A4FA-38E8-4B36-B3E8-89762C52970AQ34791525-D4CF106F-6FBC-498D-BD84-FD436FEF8AF1Q34791536-DDD84FA4-8666-4AC1-8996-954505B42A92Q34791546-2EF8E19E-D9DF-4332-83E1-8C5516D36268Q34791556-B8153502-8C15-4678-9D8E-D7C63C92410EQ34791564-8A97E084-C5EE-4A92-8AED-EBA116AE3442Q36680437-02EFFFC8-E1CE-45E8-9D68-D004D3593EA1Q36791305-6A81A739-1B8B-4DC9-92FE-DBBA54C7D1A7Q36862138-E1696CBB-17A2-49BB-82E6-9581F852D8C1Q38557890-76298761-B242-4528-BDE9-02A8614B189EQ38575276-813D726C-8FD0-4872-B67A-FBCFDDC533CF
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
name
Pharmaceutical biotechnology
@ast
Pharmaceutical biotechnology
@en
Pharmaceutical biotechnology
@es
Pharmaceutical biotechnology
@it
Pharmaceutical biotechnology
@nl
type
label
Pharmaceutical biotechnology
@ast
Pharmaceutical biotechnology
@en
Pharmaceutical biotechnology
@es
Pharmaceutical biotechnology
@it
Pharmaceutical biotechnology
@nl
altLabel
Pharm Biotechnol
@en
prefLabel
Pharmaceutical biotechnology
@ast
Pharmaceutical biotechnology
@en
Pharmaceutical biotechnology
@es
Pharmaceutical biotechnology
@it
Pharmaceutical biotechnology
@nl
P1055
P1156
P1476
Pharmaceutical biotechnology
@en
P236
P3417
Pharmaceutical-Biotechnology